Pulsed Field versus Radiofrequency Ablation for Paroxysmal AF: Randomized Comparison of Hemolysis and Myocardial Injury Using Circular PFA Catheter
In a randomized trial of 60 patients with paroxysmal atrial fibrillation, circular pulsed field ablation was found to cause significantly greater intraprocedural hemolysis and higher apoptotic cell rates but resulted in significantly lower myocardial injury compared to radiofrequency ablation.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
The human heart is a relentless pump, but sometimes its electrical rhythm falters, leading to a condition called atrial fibrillation. In this state, the upper chambers of the heart quiver instead of beating with a steady, powerful thump. This irregularity increases the risk of stroke and heart failure, making it a significant public health concern. For decades, the standard way to fix this rhythm was to use heat to create tiny scars on the heart tissue, effectively isolating the chaotic signals. This method, known as radiofrequency ablation, has been the gold standard because it works, but it carries a risk of damaging nearby structures like the esophagus or nerves due to the intense heat involved.
Recently, a new technology has emerged that aims to stop the heart's electrical chaos without using heat at all. Instead of burning the tissue, this method, called pulsed field ablation, uses very short, high-voltage electrical pulses to create microscopic holes in the cell membranes of the heart muscle. These holes cause the cells to die and form a scar, but the theory is that the surrounding blood vessels and nerves remain unharmed because they are less sensitive to this specific type of electricity. While this approach promises to be safer and faster, early reports suggested it might cause a different kind of problem: it could rupture red blood cells as they pass through the heart during the procedure, a process known as hemolysis. This raised a critical question for doctors: does this new, non-thermal method trade one set of risks for another, or can it be made safe enough to become the new standard?
Researchers at the Affiliated Hospital of Xuzhou Medical College set out to answer this question by directly comparing the new electrical method against the traditional heat-based approach. They recruited sixty patients with a specific type of irregular heartbeat called paroxysmal atrial fibrillation and randomly assigned them to two groups. One group received the traditional treatment using heat, while the other received the new treatment using a circular catheter that delivers electrical pulses. The team was particularly interested in two things: how much damage the procedure caused to the heart muscle itself, and how much it damaged the red blood cells flowing through the heart. To measure this, they drew blood from the patients before the procedure began and immediately after it ended, looking for specific chemical markers that appear when cells are injured or broken apart.
The results of the study revealed a clear trade-off between the two methods. The patients who received the new electrical treatment showed significantly higher levels of free hemoglobin in their blood after the procedure compared to those who received the heat treatment. Free hemoglobin is the pigment inside red blood cells that is released when those cells break open, so a higher level indicates that more red blood cells were destroyed during the procedure. The researchers also measured bilirubin, a substance produced when the body breaks down old red blood cells, and found that levels of total, direct, and indirect bilirubin were all higher in the electrical group. They even used a specialized microscope technique to count the percentage of cells undergoing a specific type of programmed death, finding that this number was higher in the group treated with electrical pulses. These findings confirm that the new circular catheter does cause more immediate damage to red blood cells than the traditional heat method.
However, the story changes when looking at the heart muscle itself. The study measured a protein called high-sensitivity troponin T, which leaks into the blood when heart muscle cells are injured. Here, the results were reversed. The group treated with the new electrical pulses had significantly lower levels of this injury marker compared to the group treated with heat. While the heat-based method caused more damage to the heart muscle, the electrical method caused less. This suggests that while the new technology is more aggressive toward red blood cells, it is gentler on the heart tissue it is trying to treat. The researchers also noted that the amount of red blood cell damage did not seem to depend on how many times the electrical pulses were delivered, suggesting the effect is consistent regardless of the duration of the procedure.
Despite the higher levels of red blood cell damage, the study observed that none of the patients developed severe clinical symptoms, such as dark urine or kidney failure, which are potential consequences of severe hemolysis. This indicates that while the blood tests showed more cell breakage, the body was able to handle it without immediate harm. The study concludes that for patients with this specific type of irregular heartbeat, the new circular electrical catheter offers a distinct advantage: it causes less injury to the heart muscle than the traditional heat method, even though it causes more temporary damage to the red blood cells. This data helps doctors weigh the risks, showing that the new technology is not a perfect solution but a different one with its own specific safety profile, potentially offering a safer path for protecting the heart muscle during rhythm correction.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.